Insider Transactions in Q2 2022 at Syros Pharmaceuticals, Inc. (SYRS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2022
|
Nancy A Simonian |
SELL
Payment of exercise price or tax liability
|
Direct |
58,883
-7.83%
|
$58,883
$1.12 P/Share
|
|
Apr 01
2022
|
Eric R Olson Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,266
-31.34%
|
$27,266
$1.12 P/Share
|
|
Apr 01
2022
|
David Roth Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,281
-31.36%
|
$27,281
$1.12 P/Share
|
|
Apr 01
2022
|
Kristin Stephens Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,115
-31.37%
|
$14,115
$1.12 P/Share
|